-
Something wrong with this record ?
YBX1 Protects against Apoptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation in PC12 Cells via Activation of the AKT/GSK3β Pathway
T. Tuerxun, X. Li, F. Lou, X. Wang, L. Ma
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Apoptosis MeSH
- PC12 Cells MeSH
- Stroke * MeSH
- DNA-Binding Proteins MeSH
- Glucose MeSH
- Brain Ischemia * MeSH
- Glycogen Synthase Kinase 3 beta * MeSH
- Rats MeSH
- Oxygen MeSH
- Oxidative Stress MeSH
- Proto-Oncogene Proteins c-akt * MeSH
- Reperfusion Injury * MeSH
- Cell Survival MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Reperfusion therapies for ischaemic stroke can induce secondary injury accompanied by neuronal death. The Y-box binding protein 1 (YBX1), an oncoprotein, is critical for regulating tumour cell proliferation and apoptosis. Thus, we wanted to know whether YBX1 could regulate neuronal cell apoptosis caused by cerebral ischaemia/reperfusion (I/R). We established a model of cerebral I/R-induced injury in vitro by oxygen-glucose deprivation/reoxygenation (OGD/R) treatment and determined YBX1 expression using Western blot. Next, the effect of YBX1 on the apoptosis and viability of OGD/R-treated PC12 cells was evaluated by flow cytometry, MTT assay, and Western blot. Besides, the release of lactate dehydrogenase (LDH) and the activity of catalase (CAT) and superoxide dismutase (SOD) were detected to evaluate oxidative stress of PC12 cells induced by OGD/R. The regulatory roles of YBX1 in the AKT/GSK3β pathway were examined by Western blot. As a result, OGD/R treatment down-regulated YBX1 expression in PC12 cells. YBX1 over-expression attenuated the growth inhibition and apoptosis of PC12 cells induced by OGD/R. Besides, the increase of LDH release and the decrease of SOD and CAT activities caused by OGD/R were reversed by YBX1 over-expression. Moreover, YBX1 over-expression could activate the AKT/GSK3β pathway in OGD/ R-treated PC12 cells. Therefore, YBX1 could protect against OGD/R-induced injury in PC12 cells through activating the AKT/GSK3β signalling pathway, and thus YBX1 has the potential to become a therapeutic target for cerebral I/R-induced injury.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22007859
- 003
- CZ-PrNML
- 005
- 20220323102126.0
- 007
- ta
- 008
- 220309s2021 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)35151240
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Tuerxun, T. $u Department of Neurointensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
- 245 10
- $a YBX1 Protects against Apoptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation in PC12 Cells via Activation of the AKT/GSK3β Pathway / $c T. Tuerxun, X. Li, F. Lou, X. Wang, L. Ma
- 504 __
- $a Literatura
- 520 9_
- $a Reperfusion therapies for ischaemic stroke can induce secondary injury accompanied by neuronal death. The Y-box binding protein 1 (YBX1), an oncoprotein, is critical for regulating tumour cell proliferation and apoptosis. Thus, we wanted to know whether YBX1 could regulate neuronal cell apoptosis caused by cerebral ischaemia/reperfusion (I/R). We established a model of cerebral I/R-induced injury in vitro by oxygen-glucose deprivation/reoxygenation (OGD/R) treatment and determined YBX1 expression using Western blot. Next, the effect of YBX1 on the apoptosis and viability of OGD/R-treated PC12 cells was evaluated by flow cytometry, MTT assay, and Western blot. Besides, the release of lactate dehydrogenase (LDH) and the activity of catalase (CAT) and superoxide dismutase (SOD) were detected to evaluate oxidative stress of PC12 cells induced by OGD/R. The regulatory roles of YBX1 in the AKT/GSK3β pathway were examined by Western blot. As a result, OGD/R treatment down-regulated YBX1 expression in PC12 cells. YBX1 over-expression attenuated the growth inhibition and apoptosis of PC12 cells induced by OGD/R. Besides, the increase of LDH release and the decrease of SOD and CAT activities caused by OGD/R were reversed by YBX1 over-expression. Moreover, YBX1 over-expression could activate the AKT/GSK3β pathway in OGD/ R-treated PC12 cells. Therefore, YBX1 could protect against OGD/R-induced injury in PC12 cells through activating the AKT/GSK3β signalling pathway, and thus YBX1 has the potential to become a therapeutic target for cerebral I/R-induced injury.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $7 D017209
- 650 12
- $a ischemie mozku $7 D002545
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a DNA vazebné proteiny $7 D004268
- 650 _2
- $a glukosa $7 D005947
- 650 12
- $a kinasa glykogensynthasy 3beta $7 D000071679
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a kyslík $7 D010100
- 650 _2
- $a buňky PC12 $7 D016716
- 650 12
- $a protoonkogenní proteiny c-akt $7 D051057
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 12
- $a reperfuzní poškození $7 D015427
- 650 12
- $a cévní mozková příhoda $7 D020521
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Li, X. $u Department of Neurointensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
- 700 1_
- $a Lou, F. $u Department of Neurointensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
- 700 1_
- $a Wang, X. $u Department of Neurointensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
- 700 1_
- $a Ma, L. $u Department of Neurointensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 67, č. 4 (2021), s. 150-157
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35151240 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/5959/fb2021a0019.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20220309 $b ABA008
- 991 __
- $a 20220323102121 $b ABA008
- 999 __
- $a ok $b bmc $g 1773009 $s 1159052
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 67 $c 4 $d 150-157 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20220309